Home / Insights / Vaxxas Initiates Program With Merck to Optimize Delivery of Next Generation Vaccines Utilizing Novel Mechanism for Immune System Activation

Vaxxas Initiates Program With Merck to Optimize Delivery of Next Generation Vaccines Utilizing Novel Mechanism for Immune System Activation

08 October 2012

Posted in — OneVentures

Share

Learn More

Share

You may also like

10 June 2023

Healthcare

Biotech ImmVirX bucks VC desert to bank raise at $75m valuation


18 June 2023

Healthcare

Vaxxas opens world-class manufacturing facility to produce needle-free vaccine patch


06 December 2022

Healthcare

Needle-free vaccine innovator banks $34m


View All

Ventured. Gained.
decor